Literature DB >> 14607857

Clinical application of beryllium lymphocyte proliferation testing.

Barbara P Barna1, Daniel A Culver, Belinda Yen-Lieberman, Raed A Dweik, Mary Jane Thomassen.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 14607857      PMCID： PMC262453          DOI： 10.1128/cdli.10.6.990-994.2003

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN： 1071-412X


× No keyword cloud information.
  48 in total

1.  Flow cytometry-based minisequencing: a new platform for high-throughput single-nucleotide polymorphism scoring.

Authors:  H Cai; P S White; D Torney; A Deshpande; Z Wang; R A Keller; B Marrone; J P Nolan
Journal:  Genomics       Date:  2000-06-01       Impact factor: 5.736

2.  Racial differences in prevalence of a supratypic HLA-genetic marker immaterial to pre-employment testing for susceptibility to chronic beryllium disease.

Authors:  Ainsley Weston; James Ensey; Kathleen Kreiss; Channa Keshava; Erin McCanlies
Journal:  Am J Ind Med       Date:  2002-06       Impact factor: 2.214

3.  Cutaneous hypersensitivity due to beryllium; a study of thirteen cases.

Authors:  G H CURTIS
Journal:  AMA Arch Derm Syphilol       Date:  1951-10

4.  A study of the immunologic aspects of chronic berylliosis.

Authors:  S D Deodhar; B Barna; H S Van Ordstrand
Journal:  Chest       Date:  1973-03       Impact factor: 9.410

Review 5.  Chronic beryllium disease. Long-term follow-up of sixty cases and selective review of the literature.

Authors:  J D Stoeckle; H L Hardy; A L Weber
Journal:  Am J Med       Date:  1969-04       Impact factor: 4.965

6.  In vitro studies on granulomatous hypersensitivity to beryllium.

Authors:  J M Hanifin; W L Epstein; M J Cline
Journal:  J Invest Dermatol       Date:  1970-10       Impact factor: 8.551

7.  HLA-DPB1 glutamate 69: a genetic marker of beryllium disease.

Authors:  L Richeldi; R Sorrentino; C Saltini
Journal:  Science       Date:  1993-10-08       Impact factor: 47.728

8.  Beryllium disease. The relation of pulmonary pathology to clinical course and prognosis based on a study of 130 cases from the U.S. beryllium case registry.

Authors:  D G Freiman; H L Hardy
Journal:  Hum Pathol       Date:  1970-03       Impact factor: 3.466

9.  Epidemiology of beryllium sensitization and disease in nuclear workers.

Authors:  K Kreiss; M M Mroz; B Zhen; J W Martyny; L S Newman
Journal:  Am Rev Respir Dis       Date:  1993-10

10.  Experimental beryllium-induced lung disease. I. Differences in immunologic responses to beryllium compounds in strains 2 and 13 guinea pigs.

Authors:  B P Barna; S D Deodhar; T Chiang; S Gautam; M Edinger
Journal:  Int Arch Allergy Appl Immunol       Date:  1984
View more
  2 in total

Review 1.  Sarcoidosis: Pitfalls and Challenging Mimickers.

Authors:  Naureen Narula; Michael Iannuzzi
Journal:  Front Med (Lausanne)       Date:  2021-01-11

2.  Involvement of Dendritic Cells and Th17 Cells in Induced Tertiary Lymphoid Structures in a Chronic Beryllium Disease Mouse Model.

Authors:  Alex KleinJan; Menno van Nimwegen; Karolina Leman; Ke-Xin Wen; Louis Boon; Rudi W Hendriks
Journal:  Mediators Inflamm       Date:  2021-05-06       Impact factor: 4.711
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.